Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-17-000243
Filing Date
2017-03-13
Accepted
2017-03-13 16:34:14
Documents
1
Period of Report
2016-12-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 9921
  Complete submission text file 0000904454-17-000243.txt   11547
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM 11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM 11 (441) 824-8101
Myovant Sciences Ltd. (Issuer) CIK: 0001679082 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address THURGAUERSTRASSE 130 GLATTPARK-OPFIKON ZURICH V8 8152
Business Address THURGAUERSTRASSE 130 GLATTPARK-OPFIKON ZURICH V8 8152 41-44-555-10-00
Takeda Pharmaceuticals International AG (Reporting) CIK: 0001688140 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 0331
Type: 4 | Act: 34 | File No.: 001-37929 | Film No.: 17685611